BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33063147)

  • 1. [
    Polverari G; Ceci F; Passera R; Crane J; Du L; Li G; Fanti S; Bernthal N; Eilber FC; Allen-Auerbach M; Czernin J; Calais J; Federman N
    EJNMMI Res; 2020 Oct; 10(1):122. PubMed ID: 33063147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Annovazzi A; Ferraresi V; Anelli V; Covello R; Vari S; Zoccali C; Biagini R; Sciuto R
    Eur Radiol; 2021 Sep; 31(9):7012-7021. PubMed ID: 33715090
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Simoni N; Rossi G; Benetti G; Zuffante M; Micera R; Pavarana M; Guariglia S; Zivelonghi E; Mengardo V; Weindelmayer J; Giacopuzzi S; de Manzoni G; Cavedon C; Mazzarotto R
    Front Oncol; 2020; 10():599907. PubMed ID: 33330097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Performance of
    Rubini G; Ferrari C; Altini C; Cimino A; Fanelli M; Niccoli Asabella A
    Curr Med Imaging Rev; 2019; 15(1):32-38. PubMed ID: 31964325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer.
    Champion L; Lerebours F; Alberini JL; Fourme E; Gontier E; Bertrand F; Wartski M
    J Nucl Med; 2015 Sep; 56(9):1315-21. PubMed ID: 26159587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer.
    Im HJ; Kim YK; Kim YI; Lee JJ; Lee WW; Kim SE
    Nucl Med Mol Imaging; 2013 Mar; 47(1):36-43. PubMed ID: 24895506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline
    Garcia-Vicente AM; Pérez-Beteta J; Amo-Salas M; Molina D; Jimenez-Londoño GA; Soriano-Castrejón AM; Pena Pardo FJ; Martínez-González A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):73-79. PubMed ID: 29102649
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Crompton JG; Armstrong WR; Eckardt MA; Seyedroudbari A; Tap WD; Dry SM; Abt ER; Calais J; Herrmann K; Czernin J; Eilber FC; Benz MR
    J Nucl Med; 2022 May; 63(5):708-712. PubMed ID: 34593596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different
    El-Hennawy G; Moustafa H; Omar W; Elkinaai N; Kamel A; Zaki I; Farid N; El-Kholy E
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28605. PubMed ID: 32706520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of
    Rufini V; Collarino A; Calcagni ML; Meduri GM; Fuoco V; Pasciuto T; Testa AC; Ferrandina G; Gambacorta MA; Campitelli M; Gui B; Zannoni G; Manfredi R; Scambia G; Giordano A
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1228-1238. PubMed ID: 31414206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic values of mid-radiotherapy
    Kim N; Cho H; Yun M; Park KR; Lee CG
    Radiat Oncol; 2019 Feb; 14(1):27. PubMed ID: 30717809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Pre- and Post-Treatment FDG PET/CT Parameters in Small Cell Lung Cancer Patients.
    Kim H; Yoo IR; Boo SH; Park HL; O JH; Kim SH
    Nucl Med Mol Imaging; 2018 Feb; 52(1):31-38. PubMed ID: 29391910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of
    Uslu-Beşli L; Mermut Ö; Yardimci AH; Gündoğan C; Gürsu RU; Çermik TF
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(1):19-29. PubMed ID: 33402312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Evaluation of Different Methods for Volumetric Analysis on [
    Lopci E; Elia C; Catalfamo B; Burnelli R; De Re V; Mussolin L; Piccardo A; Cistaro A; Borsatti E; Zucchetta P; Bianchi M; Buffardi S; Farruggia P; Garaventa A; Sala A; Vinti L; Mauz-Koerholz C; Mascarin M
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
    Lorenzen S; von Gall C; Stange A; Haag GM; Weitz J; Haberkorn U; Lordick F; Weichert W; Abel U; Debus J; Jäger D; Münter MW
    BMC Cancer; 2011 Jun; 11():266. PubMed ID: 21702914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.
    Leseur J; Roman-Jimenez G; Devillers A; Ospina-Arango JD; Williaume D; Castelli J; Terve P; Lavoue V; Garin E; Lejeune F; Acosta O; De Crevoisier R
    Radiother Oncol; 2016 Sep; 120(3):512-518. PubMed ID: 27569847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early response monitoring of neoadjuvant chemotherapy using [
    Lee I; Byun BH; Lim I; Kim BI; Choi CW; Koh JS; Song WS; Cho WH; Kong CB; Lim SM
    EJNMMI Res; 2020 Jan; 10(1):1. PubMed ID: 31900594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.
    Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G
    Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of volumetric metabolic parameter changes determined by during and after radiotherapy-based
    Chen HHW; Su WC; Guo HR; Lee BF; Chiu NT
    Kaohsiung J Med Sci; 2019 Mar; 35(3):151-159. PubMed ID: 30887722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of baseline
    Reyes Marlés RH; Navarro Fernández JL; Puertas García-Sandoval JP; Santonja Medina F; Mohamed Salem L; Frutos Esteban L; Contreras Gutiérrez JF; Castellón Sánchez MI; Ruiz Merino G; Claver Valderas MA
    Eur J Hybrid Imaging; 2021 Sep; 5(1):16. PubMed ID: 34476632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.